FluxMPS™ Medium 199 (M199), [2X]

Product#: Medium1992X
$0.00

Select See the table below

  • See the table below

Availability:
Ships in 48 hours

Built on Morgan, Morton & Parker's 1950 Synthetic Medium Platform

FluxMPS™ Medium 199 (M199), [2X]

Medium 199 is a cell culture medium developed in 1950 by J.F. Morgan, primarily for cultivating chick embryo fibroblasts and other mammalian cells. It features a balanced composition of salts, amino acids, vitamins, and glucose, but lacks proteins and growth factors. FluxMPS™ delivers this historic formulation through a 0.04 micron quadruple-stage filtration process engineered for microfluidic, Organ-on-Chip (OoC), and Lab-on-Chip (LoC) platforms.

  • Four planned FluxMPS™ configurations: M199, 2X, M199, 2X w/o Bicarbonate, M199, 2X + HEPES, and M199, 2X + HEPES w/o Bicarbonate — all currently listed as Coming Soon
  • Often used in virology and vaccine production; requires a CO2-enriched environment to maintain its pH
  • Standard glucose concentration of 2000 mg/L and standard HEPES buffer concentration of 25mM at 2X (see composition note below regarding the source's "Galactose" wording)
  • Configurations vary by L-Glutamine, Sodium Bicarbonate, HEPES, and Phenol Red inclusion; all four configurations include L-Glutamine and Phenol Red
  • Purified through FluxMPS™ quadruple-stage 0.04 micron filtration for microfluidic and Organ-on-Chip / Tissue-on-Chip / Lab-on-Chip compatibility
  • Supports various cell types and is typically supplemented with serum or serum-free additives for optimal growth; its defined formulation makes it particularly valuable in large-scale vaccine manufacturing and biomedical research
  • Available in 500 mL and 1000 mL sizes; stored at 2-8°C away from bright light; fully customizable via support@diagnocine.com
DCP-M199...2X
FluxMPS™ Medium 199 (M199), 2X Family — 2X Liquid
  • Concentration2X
  • Glucose (per source: "Galactose")2000 mg/L
  • HEPES buffer25mM (standard, HEPES configurations)
  • L-GlutamineIncluded (all four)
  • Sodium BicarbonateVariant-dependent
  • HEPESVariant-dependent
  • Phenol RedIncluded (all four)
  • Sizes500 mL / 1000 mL
  • Storage2-8°C, protect from light
  • AvailabilityComing Soon
RUO Morgan, Morton & Parker 1950 Foundational Customizable
Configuration

At-a-Glance Supplement Matrix

Check the supplement(s) you require, press Search to confirm which configuration(s) include them. All four Medium 199 configurations below are currently listed as Coming Soon in Diagnocine's source materials; contact support@diagnocine.com for availability updates or early access.

Filter by included supplements
 
Medium 199 (M199) Family — Configurations
At-a-glance supplement matrix — all configurations currently Coming Soon.
Name Cat No. L-Glutamine Bicarbonate HEPES Phenol Red Availability
M199 DCP-M1992X check check remove check scheduleComing Soon
M199 w/o Bicarbonate DCP-M199-B2X check remove remove check scheduleComing Soon
M199 + HEPES DCP-M199H2X check check check check scheduleComing Soon
M199 + HEPES w/o Bicarbonate DCP-M199H-B2X check remove check check scheduleComing Soon
Availability: All four Medium 199 configurations are marked "Coming Soon" in Diagnocine's source materials; no product page URLs are yet available for individual configurations. Catalog numbers above are shown as reference identifiers only, not as active links. Contact support@diagnocine.com for availability updates.
Customization: Standard configuration is 2X concentration with 2000 mg/L standard glucose (listed as "Galactose" in the source customization note — see the composition section below for discussion) and 25mM standard HEPES buffer concentration. Please contact support@diagnocine.com to inquire about other concentrations, additions of chemicals, compounds, proteins, or supplements, a different pH, and other modifications as needed.
Family Overview

About Medium 199 (M199)

Medium 199 is a cell culture medium developed in 1950 by J.F. Morgan, primarily for cultivating chick embryo fibroblasts and other mammalian cells. It features a balanced composition of salts, amino acids, vitamins, and glucose, but lacks proteins and growth factors. Often used in virology and vaccine production, Medium 199 requires a CO2-enriched environment to maintain its pH. It supports various cell types and is typically supplemented with serum or serum-free additives for optimal growth. Its defined formulation makes it particularly valuable in large-scale vaccine manufacturing and biomedical research.

Origins & Development

Medium 199 (M199, also designated TCM 199 or Tissue Culture Medium 199) is the first completely defined, synthetic cell culture medium developed for the nutritional study of animal cells in vitro. Formulated in 1950 at the Connaught Medical Research Laboratories (CMRL) at the University of Toronto by Joseph F. Morgan, Helen J. Morton, and Raymond C. Parker, it represented an unprecedented attempt to replace all undefined biological supplements with a precisely characterized chemical mixture.

Unlike the Eagle-lineage media (BME, MEM, DMEM) that followed, built around the minimal nutrients needed to sustain proliferating cell lines, Medium 199 was engineered from a maximalist nutritional philosophy: every class of compound believed on theoretical grounds to be required by living cells was included, whether its individual necessity had been experimentally confirmed or not. This produced a uniquely complex formulation containing not only amino acids, water-soluble vitamins, and inorganic salts, but also fat-soluble vitamins (A, D2, E, K3), cholesterol, nucleic acid precursors (free purines, pyrimidines, nucleosides, nucleotides), and the surfactant polysorbate 80 (Tween 80) as a lipid dispersant, a nutritional scope not matched by any other classical medium.

Before 1950, all tissue culture media relied on undefined biological fluids, plasma clots, embryo extract, serum, and lymph as the principal nutritional components. These supplements were irreplaceable for cell maintenance, but their variable, unknown composition precluded controlled nutritional experiments. The CMRL group at the University of Toronto, under Raymond C. Parker, was at the forefront of replacing biological supplements with synthetic ones; the aim of the 1950 project was specifically to create a tool for the nutritional study of primary chick embryo fibroblasts under chemically defined conditions.

Morgan, Morton, and Parker published their foundational result in January 1950 as "Nutrition of animal cells in tissue culture; initial studies on a synthetic medium" in Proceedings of the Society for Experimental Biology and Medicine (73(1): 1-8). The paper described a fully synthetic feeding solution combining amino acids, vitamins, nucleic acid constituents, and accessory growth factors. The authors demonstrated that explanted chick embryo cells could survive in this mixture without serum for an average of four to five weeks, with measurable growth — results not achieved with any prior synthetic formulation. The investigators noted that while Medium 199 sustained cell life and permitted nutritional study, it was insufficient for long-term proliferation without serum, a limitation acknowledged in the original paper and all subsequent product documentation.

The number "199" reflects the sequential numbering of experimental formulations tested during development, not a count of components. Yao and Asayama (2017) describe the philosophy precisely: Medium 199 includes fat-soluble vitamins, cholesterol, and other components considered necessary on theoretical grounds, some of which proved physiologically inactive. This placed Medium 199 in deliberate contrast with the subsequent Eagle approach (1955-1959), which sought to define minimal requirements empirically; Eagle criticized Medium 199's complexity, noting that it included many components demonstrably unnecessary for HeLa and L-cell growth, and used this as the rationale for developing BME.

Tween 80 and the Delivery of Fat-Soluble Vitamins

The introduction of Tween 80 into the Medium 199 program is documented in Morton, Morgan & Parker (1950), "Nutrition of animal cells in tissue culture. II. Use of Tweens in synthetic feeding mixtures" (Proc. Soc. Exp. Biol. Med. 74: 22-26). Delivering fat-soluble vitamins was a practical problem, since vitamins A, D2, E, and K3 (menadione) are insoluble in aqueous media. Polysorbate 80 served as a nonionic surfactant vehicle that maintained these lipophilic compounds in stable suspension. Tween 80 also emulsifies cholesterol (0.2 mg/L), the only sterol present in any classical cell culture medium; this Tween 80 plus cholesterol pairing is absent from all subsequent Eagle-lineage media (BME, MEM, DMEM, IMDM, RPMI 1640).

Connaught Lineage: Medium 199 and CMRL 1066

Medium 199 and CMRL 1066 (Parker et al., 1957) both emerged from the same CMRL group and share a direct developmental relationship. CMRL 1066 was created by amending Medium 199 to culture mouse L cells under protein-free conditions: increasing the reducing substances cysteine, glutathione, and ascorbic acid; eliminating the fat-soluble vitamins (A, D, E, K3) and Tween 80; changing the nucleic acid precursors; and adding five preformed coenzymes (CoA, TPP, NAD, NADP, FAD). CMRL 1066 is thus a more metabolically sophisticated, serum-free-optimized descendant of Medium 199's complex basal framework.

Medium 199 and the 1955 Salk Polio Vaccine

The most historically consequential application of Medium 199 was as the growth medium for the poliovirus used to produce the first Salk inactivated polio vaccine. Following the Enders-Weller-Robbins discovery that poliovirus could be grown in non-nervous tissue cultures (Nobel Prize, 1954), Medium 199 was selected as the nutrient medium for growing poliovirus in monkey kidney cell monolayers. Contemporary accounts describe minced monkey kidney tissue placed in "Povitzky bottles" filled with Mixture 199, incubated at 36-37 degrees C for several days to form a kidney-cell monolayer, after which fresh Mixture 199 was added and poliovirus seed inoculated; the virus multiplied for several days before harvest. The April 12, 1955 announcement of vaccine efficacy and the subsequent mass inoculation of millions of children marked the first global public-health triumph in which a chemically defined synthetic medium played a central role in manufacturing.

Lineage

The Medium 199 / CMRL Family Tree

  • Medium 199 (1950) — Morgan, Morton & Parker, Connaught Medical Research Laboratories (CMRL), University of Toronto. The first completely defined, synthetic medium for chick embryo fibroblast nutritional study, built on a maximalist theoretical-provision philosophy.
  • CMRL 1066 (1957) — Parker et al., a direct descendant created by amending Medium 199 to culture mouse L cells under protein-free conditions: increased cysteine, glutathione, and ascorbic acid; eliminated fat-soluble vitamins and Tween 80; changed nucleic acid precursors; added five preformed coenzymes.
  • Eagle-lineage media (BME, MEM, DMEM) — a contrasting philosophy (1955-1959). Harry Eagle criticized Medium 199's complexity, noting many components were demonstrably unnecessary for HeLa and L-cell growth, and used this as rationale for developing BME on minimal empirical requirements rather than maximal theoretical provision.
  • M199 salt variants — Earle's salts (closed CO2 system, higher phosphate) and Hanks' salts (open system, lower phosphate, higher NaCl) are functionally non-equivalent configurations of the same base formulation.
Composition

Composition

The tables below present the full source-verified composition of the standard Earle's Salts Medium 199 formulation (with L-Glutamine), the broadest nutritional profile of any classical cell culture medium, including fat-soluble vitamins, cholesterol, nucleic acid precursors, and Tween 80 — features absent from all Eagle-lineage media.

On the 2X designation: This product line is formulated at 2X (double) standard concentration, intended for a 1:1 dilution to reach standard 1X working strength. Diagnocine's product-page customization note confirms a standard glucose (listed as "Galactose" — see data note below) concentration of 2000 mg/L for this 2X line, exactly double the 1000 mg/L documented for the standard 1X Medium 199 formulation in Diagnocine's background materials. The ingredient tables below reproduce the source-verified standard (1X-referenced) composition profile; at 2X concentration, each listed component is present at twice the tabulated value prior to dilution.
Data note (Glucose vs. "Galactose"): Diagnocine's product-page customization note lists "2000 mg/L standard Galactose concentration." Diagnocine's broader Medium 199 background material documents D-Glucose at 1000 mg/L as the standard sugar component, with no mention of galactose anywhere in the formulation. This appears to be a wording inconsistency in the source datasheet; both figures are reported here as they appear in their respective source documents, without asserting which is correct. Researchers should verify the carbohydrate source against a Certificate of Analysis before use.
Medium 199 — Inorganic Salts (Earle's Salt Set)
Ingredient mg/L
Calcium chloride dihydrate 265.000
Ferric nitrate nonahydrate [Fe(NO3)3.9H2O] 0.720
Magnesium sulfate (anhydrous) 97.67
Potassium chloride 400.000
Sodium acetate (anhydrous) 50.000
Sodium chloride 6800.000
Sodium dihydrogen phosphate (anhydrous) 122.000
Medium 199 contains 21 amino-acid entries: 19 proteinogenic amino acids (asparagine is absent), with cysteine present as both free L-cysteine.HCl and L-cystine (two entries), plus the non-standard amino acid L-hydroxyproline — the broadest amino-acid profile of any classical medium in the Eagle/CMRL lineage. The original 1950 formulation used DL-racemic mixtures at full concentration; modern commercial formulations substitute the L-enantiomers in a molar-equivalent amount (roughly half the mass).
Medium 199 — Amino Acids
Ingredient mg/L
Glycine 50.000
L-Alanine 25.000
L-Arginine hydrochloride 70.000
L-Aspartic acid 30.000
L-Cysteine hydrochloride monohydrate 0.100
L-Cystine dihydrochloride 26.000
L-Glutamic acid 67.000
L-Glutamine 100.000
L-Histidine hydrochloride monohydrate 21.880
L-Hydroxyproline 10.000
L-Isoleucine 20.000
L-Leucine 60.000
L-Lysine hydrochloride 70.000
L-Methionine 15.000
L-Phenylalanine 25.000
L-Proline 40.000
L-Serine 25.000
L-Threonine 30.000
L-Tryptophan 10.000
L-Tyrosine disodium salt dihydrate 57.660
L-Valine 25.000
Medium 199 contains the most comprehensive vitamin complement of any classical medium: 13 water-soluble vitamins (including both B3 forms and both B6 forms, plus PABA) and four fat-soluble vitamins.
Medium 199 — Vitamins
Ingredient mg/L
Ascorbic acid (Vitamin C) 0.050
Calciferol (Ergocalciferol, Vitamin D2) 0.100
Choline chloride 0.500
D-Biotin 0.010
D-Calcium pantothenate 0.010
DL-alpha-Tocopherol phosphate disodium salt (Vitamin E) 0.010
Folic acid 0.010
Menadione (Vitamin K3) 0.016
myo-Inositol 0.050
Niacinamide (Nicotinamide) 0.025
Nicotinic acid (Niacin) 0.025
p-Aminobenzoic acid (PABA) 0.050
Pyridoxal hydrochloride 0.025
Pyridoxine hydrochloride 0.025
Retinol acetate (Vitamin A acetate) 0.140
Riboflavin 0.010
Thiamine hydrochloride 0.010
Key vitamin features: (1) Vitamins A (retinol acetate), D2 (ergocalciferol), E (alpha-tocopherol phosphate), and K3 (menadione) are all present and require Tween 80 for suspension; no other classical medium contains vitamins A, D, and E simultaneously in the base formulation (the D2 entry is formulation-dependent). (2) Both pyridoxal HCl and pyridoxine HCl (dual B6, 0.025 each) and both nicotinamide and nicotinic acid (dual B3, 0.025 each) reflect the maximal-provision philosophy. (3) PABA (0.050 mg/L) is present in Medium 199 and CMRL 1066 but absent from all Eagle-lineage media. (4) Vitamin B12 is absent from Medium 199, distinguishing it from MCDB 105/153 and IMDM, but consistent with Eagle-lineage media.
Nucleic acid precursors and energy substrates: this group is the most structurally distinctive feature of Medium 199, entirely absent from all Eagle-lineage basal media (BME, MEM, DMEM, IMDM, alpha-MEM).
Medium 199 — Nucleic Acid Precursors & Energy Substrates
Ingredient mg/L
Adenine sulfate 10.000
Adenosine 5'-triphosphate disodium (ATP) 1.000
Adenosine 5'-monophosphate sodium (5'-AMP) 0.200
Guanine hydrochloride 0.300
Hypoxanthine (sodium) 0.300
Thymine 0.300
Uracil 0.300
Xanthine sodium 0.344
2-Deoxy-D-ribose 0.500
D-Ribose 0.500
ATP at 1.0 mg/L is present as an exogenous energy source, unusual among classical media (also present in CMRL 1066). The free purines (adenine, guanine, hypoxanthine, xanthine) and pyrimidines (thymine, uracil) permit nucleic-acid synthesis via salvage; both DNA and RNA sugar precursors (deoxyribose, ribose) reflect the maximal-provision philosophy.
Medium 199 — Lipid Components
Ingredient mg/L
Cholesterol 0.200
Polysorbate 80 (Tween 80) 4.900-20.000
Medium 199 — Other Components
Ingredient mg/L
D-Glucose 1000.000
Glutathione (reduced, GSH) 0.050
Sodium acetate (anhydrous) 50.000
HEPES buffer 5958.000
Phenol red sodium salt ~10-20
Reduced glutathione (0.050 mg/L) acts as an antioxidant approximately 200 times lower than in CMRL 1066 (10.0 mg/L), reflecting CMRL 1066's design for protein-free, serum-free culture. Glucose at 1000 mg/L (~5.5 mM) matches DMEM low-glucose, MEM, and CMRL 1066, not the 4500 mg/L of high-glucose DMEM.

Salt Variants: Earle's vs. Hanks' Salts

Medium 199 is documented in two salt configurations that affect buffering, CO2 dependence, and phosphate levels, making the variants functionally non-equivalent. Diagnocine's configurations are based on the Earle's salts variant described below.

Feature Earle's Salts Variant Hanks' Salts Variant
NaHCO3 added by user 2.2 g/L (closed CO2 system) Not added (or low, ~0.35 g/L)
CO2 atmosphere required 5-10% Not required (open system, ambient air)
Phosphate content Higher (NaH2PO4 122 mg/L anhydrous) Lower phosphate
NaCl 6800 mg/L Higher (~8000 mg/L) to compensate osmotically
Principal application Standard closed-incubator culture Open systems, brief ex vivo work, non-CO2 transport
Buffering Active bicarbonate/CO2 equilibrium Relies more on phosphate buffering
Oocyte IVM use Dominant (CO2 incubator) Collection flushes/transport
The functional importance of this distinction was shown in a pig oocyte maturation study (Hagen, Prather, Minhas & First, 1986; Biol. Reprod. 35(3): 658-661): replacing Earle's (bicarbonate/CO2) buffering with Hanks' (phosphate) buffering decreased polar-body formation, and restoring supplemental bicarbonate restored maturation, indicating that bicarbonate itself plays a mechanistic role in oocyte maturation beyond simple pH regulation.
Comparison

Medium 199 vs. Classical Media: Comprehensive Comparison

How Medium 199's maximalist nutritional philosophy compares to Eagle-lineage media (BME, MEM, DMEM) and its direct descendant, CMRL 1066.

Feature Medium 199 BME MEM DMEM (high-glucose) CMRL 1066
Developer & year Morgan, Morton, Parker — CMRL, 1950 Eagle — NIH, 1955 Eagle — NIH, 1959 Dulbecco & Freeman, 1959 Parker et al. — CMRL, 1957
Amino acids 19 proteinogenic (no Asn) + cystine + Hyp = 21 entries 13 (essential set) 13 (essential set) 15 (+ Gly, Ser) ~20 (incl. Hyp, non-essentials)
Fat-soluble vitamins A, D2, E, K3 None None None None
Water-soluble vitamins 13 (both B3, both B6, PABA, ascorbate, biotin, pantothenate, folate, riboflavin, thiamine, choline, inositol) 9 (incl. biotin) 8 (no biotin) 8 (no biotin, no B12) 15+ (adds CoA, TPP, NAD, NADP, FAD)
Glucose 1000 mg/L (~5.5 mM) 1000 mg/L 1000 mg/L 4500 mg/L (25 mM) 1000 mg/L
Cholesterol 0.200 mg/L None None None None
Tween 80 4.9-20 mg/L None None None None
ATP (exogenous) 1.000 mg/L None None None 1.000 mg/L
Free purines Adenine, guanine, hypoxanthine, xanthine None None None Modified set
Free pyrimidines Thymine, uracil None None None Modified set
Reduced glutathione 0.050 mg/L None None None 10.000 mg/L
Ascorbic acid 0.050 mg/L None None None 0.050 mg/L
PABA 0.050 mg/L None None None 0.050 mg/L
L-Hydroxyproline 10.000 mg/L None None None 10.000 mg/L
Sodium pyruvate None None None 110 mg/L (variant) None
Iron source Fe(NO3)3.9H2O 0.720 mg/L None None Fe(NO3)3.9H2O 0.1 mg/L Absent
Selenium None None None None None
HEPES 25 mM (HEPES variant) None None None None
Sodium bicarbonate 2.2 g/L; 5-10% CO2 CO2-dependent CO2-dependent CO2-dependent CO2-dependent
pH / osmolality ~7.2 / 310-350 mOsm/kg (with NaHCO3) ~7.2 / 290-300 ~7.2 / ~290 ~7.2 / ~335 ~7.2 / ~280
Serum requirement Not self-sufficient; 5-15% FBS 5-10% FBS 5-10% FBS 10% FBS 5% for some lines
Primary application Virology, vaccine production, vascular cells, oocyte IVM General adherent lines General adherent lines High-density adherent lines, HEK293 Mouse L cells, protein-free
Historical milestone Salk polio vaccine production, 1955 Defined minimal requirements Doubled amino acids Polyoma plaque assay First serum-free mammalian line culture
The CMRL 1066 iron entry is confirmed as "Absent" in Diagnocine's verified reference for CMRL 1066, which has no iron salt in its base formulation.

Distinctive Compositional Features vs. Classical Media

Features of Medium 199 documented as absent from all Eagle-lineage media (BME, MEM, DMEM, IMDM, alpha-MEM, RPMI 1640) and MCDB media:

  • Fat-soluble vitamins (A, D2, E, K3) — the only classical medium to include all four (D2 formulation-dependent)
  • Polysorbate 80 (Tween 80) — nonionic surfactant for lipid dispersal
  • Cholesterol (0.2 mg/L) — the only exogenous sterol in any classical medium's base
  • ATP (1.0 mg/L) — exogenous energy currency (also in CMRL 1066)
  • Free purines (guanine, hypoxanthine, xanthine) and pyrimidines (thymine, uracil) — salvage substrates (present in CMRL 1066)
  • Both ribose and deoxyribose as RNA and DNA sugar precursors
  • L-Hydroxyproline (10 mg/L) — non-standard amino acid (also in CMRL 1066)
  • Both vitamin B6 forms (pyridoxal + pyridoxine) and both B3 forms (nicotinamide + nicotinic acid)
  • PABA (0.050 mg/L) — present in M199 and CMRL 1066
  • Reduced glutathione (0.050 mg/L) — approximately 200 times lower than CMRL 1066
  • Ascorbic acid (0.050 mg/L) — present in alpha-MEM and L-15; absent from DMEM/MEM/BME
  • Sodium acetate (50 mg/L) — absent from DMEM and MEM
FluxMPS™ Advantage

Why FluxMPS™

filter_alt

Quadruple-Stage 0.04 Micron Filtration

Purified finer than any ready-to-use cell culture media currently available, removing particulates and protein aggregates before they reach the chip.

device_hub

Engineered for Microfluidic Flow

Formulated for Organ-on-Chip (OoC), Tissue-on-Chip (ToC), and Lab-on-Chip (LoC) platforms, where the medium is itself part of the instrument.

visibility

Optical Clarity

Supports real-time imaging and integrated biosensing across long-duration culture and perfusion studies.

science

Historic Vaccine-Production Heritage

Rooted in the medium used to grow the poliovirus for the first Salk inactivated polio vaccine in 1955.

tune

Fully Customizable

Standard 2X concentration, glucose, and HEPES levels can be adjusted, along with chemical additions, proteins, supplements, and pH, on request.

verified

Regulatory-Aligned Foundation

Formulated to support FDA-recognized physiological modeling standards for drug discovery, toxicology screening, and translational research.

Manufacturing

Quadruple-Stage Filtration

Every FluxMPS™ formulation, including Medium 199, passes through a four-stage filtration architecture before reaching your platform.

  • 1

    0.1µmPre-filtration Stage One

    Removes larger particulates and aggregates from the formulated medium.

  • 2

    0.1µmPre-filtration Stage Two

    A second 0.1 micron pass further reduces particulate and aggregate load ahead of sterile filtration.

  • 3

    0.04µmSterile Filtration Stage One

    Fine sterile filtration engineered for microfluidic channel compatibility.

  • 4

    0.04µmSterile Filtration Stage Two

    A second 0.04 micron pass for the optical clarity and particulate control that OoC/ToC/LoC platforms require.

Filtration Performance

4
Sequential filtration stages
0.04µm
Finest sterile-filtration pore size
FluxMPS™ Medium 199 Quadruple-stage filtration system diagram ? two 0.1 micron pre-filtration stages followed by two 0.04 micron sterile-filtration stages, engineered for organ-on-a-chip (OoC), tissue-on-a-chip (ToC), and lab-on-a-chip microfluidic cell culture media applications by Diagnocine.
Validated Use

Validated Cell Lines & Applications

egg

Chick Embryo Fibroblasts

The primary validated cell type; the 1950 paper demonstrated maintenance for four to five weeks without serum.

coronavirus

Monkey Kidney / Vero Cells

Used for rabies, Japanese encephalitis, and other viral vaccine production (M199 + 10% FBS); the original Salk vaccine substrate.

biotech

BHK-21 Cells

Used for foot-and-mouth disease and rabies vaccine production.

favorite

Vascular Smooth Muscle & Endothelial Cells

Rat, rabbit, and human aortic cells (M199 + 10% FBS under 5% CO2), with good growth and minimal fibroblast contamination.

monitor_heart

Cardiomyocyte Isolation

Used in neonatal rat ventricular cardiomyocyte isolation and enzymatic digestion, and for short-term chick cardiomyocyte culture maintaining spontaneous beating.

egg_alt

Oocyte In Vitro Maturation (IVM)

TCM 199 is the universal standard basal medium for bovine, porcine, equine, and ovine oocyte IVM — its single largest contemporary application volume.

Scientific Use

Scientific Applications

vaccines

Virology & Vaccine Production

General-purpose virology, where serum-supplemented M199 provides the broad nutritional base for primary lines, including the historic 1955 Salk polio vaccine manufacturing process.

science

Reproductive Biology & IVF/IVM

Bovine IVM (with serum, gonadotropins FSH/LH, and estradiol) is the worldwide standard maturation medium; porcine IVM uses TCM 199 (Earle's) with follicular fluid, eCG, and hCG at 38.5 degrees C, 5% CO2 for approximately 44-46 hours.

biotech

Primary Explant & Organ Culture

Used for mouse pancreatic epithelial explants, rat lens epithelial tissue, and organ culture generally, reflecting its broad nutritional base.

bug_report

Arthropod Cell Culture

Used as a component in some arthropod (tick, mosquito) cell systems, occasionally useful in custom tick-borne pathogen culture systems.

Handling

Practical Considerations & Limitations

Cholesterol / Tween 80 compatibility. Polysorbate 80 can interact with lipophilic membrane components and certain cell types above the recommended range, and with some plastics, protein-binding surfaces, and filtration membranes; verify the concentration (4.9-20 mg/L) when changing suppliers.

Glutamine instability. L-glutamine (100 mg/L) is subject to spontaneous cyclization to pyroglutamate; store at 2-8°C and use within shelf life, or use a stable dipeptide (L-alanyl-L-glutamine).

Fat-soluble vitamin photodegradation. Vitamins A, D2, E, and K3 are photosensitive; store in a light-protected manner at 2-8°C and use freshly prepared medium promptly.

Serum dependency. Despite its complexity, Medium 199 does not support continuous proliferation without serum for most cell types — it is a complex basal medium, not a serum-free system.

Nucleotide precursor redundancy. Many nucleic acid precursors are physiologically redundant in proliferating lines with intact biosynthetic pathways; their benefit is greatest in cells with impaired de novo synthesis (primary explants, low density, metabolic stress).

Preparation and buffering (per source materials): For the powder reconstituted to 1 L: suspend approximately 15.5 g in 900 mL tissue-culture-grade water with gentle stirring (do not heat); add 2.2 g NaHCO3 (or 29.3 mL of 7.5% NaHCO3) per liter; adjust pH to 0.2-0.3 units below the desired final value (pH rises during filtration); make up to 1000 mL and sterilize immediately by ≤0.22 µm filtration using positive pressure to minimize CO2 loss. In the HEPES-modified variant, 25 mM HEPES is incorporated into the powder to provide supplementary buffering at culture initiation; NaHCO3 is still added to maintain physiological CO2 equilibrium.
FAQ

Frequently Asked Questions

All four Medium 199 configurations are currently listed as Coming Soon in Diagnocine's source materials. Contact support@diagnocine.com for availability updates or early access.
All four include L-Glutamine and Phenol Red. M199 (DCP-M1992X) includes sodium bicarbonate but not HEPES; M199 w/o Bicarbonate (DCP-M199-B2X) has neither; M199 + HEPES (DCP-M199H2X) includes both sodium bicarbonate and HEPES; M199 + HEPES w/o Bicarbonate (DCP-M199H-B2X) includes HEPES but not sodium bicarbonate.
Medium 199 was developed primarily for cultivating chick embryo fibroblasts and other mammalian cells. It is widely used for monkey kidney/Vero cells, BHK-21 cells, vascular smooth muscle and endothelial cells, cardiomyocyte isolation, and as the universal standard medium for bovine, porcine, equine, and ovine oocyte in vitro maturation.
Yes. FluxMPS™ purifies this formulation through a quadruple-stage filtration process down to 0.04 microns, engineered for Organ-on-Chip (OoC), Tissue-on-Chip (ToC), and Lab-on-Chip (LoC) microfluidic platforms.
Medium 199 lacks proteins and growth factors and is typically supplemented with serum or serum-free additives for optimal growth. Despite its complex formulation, it does not support continuous proliferation without serum for most cell types.
The product-page customization note lists "2000 mg/L standard Galactose concentration," while Diagnocine's broader Medium 199 background material documents D-Glucose at 1000 mg/L as the standard sugar component. This appears to be a wording inconsistency between source documents; researchers should verify the carbohydrate source against a Certificate of Analysis before use.
Medium 199 is available in 500 mL and 1000 mL sizes. Store at 2-8°C, away from bright light.
Medium 199 follows a maximalist nutritional philosophy, including fat-soluble vitamins, cholesterol, Tween 80, and nucleic acid precursors absent from all Eagle-lineage media. Eagle criticized this complexity and developed BME around a minimal, empirically determined nutrient set instead.
Bibliography

Verified References

  • Morgan, J.F., Morton, H.J. & Parker, R.C. (1950). Nutrition of animal cells in tissue culture. I. Initial studies on a synthetic medium. Proc. Soc. Exp. Biol. Med., 73(1): 1-8. PMID 15402504. DOI 10.3181/00379727-73-17557.
  • Morton, H.J., Morgan, J.F. & Parker, R.C. (1950). Nutrition of animal cells in tissue culture. II. Use of Tweens in synthetic feeding mixtures. Proc. Soc. Exp. Biol. Med., 74: 22-26.
  • Morgan, J.F., Campbell, M.E. & Morton, H.J. (1955). The nutrition of animal tissues cultivated in vitro. I. A survey of natural materials as supplements to synthetic Medium 199. J. Natl. Cancer Inst., 16: 557-567.
  • Hagen, D.R., Prather, R.S., Minhas, B.S. & First, N.L. (1986). Effects of incubation temperature and bicarbonate on maturation of pig oocytes in vitro. Biol. Reprod., 35(3): 658-661. PMID 3701704.
  • Yao, T. & Asayama, Y. (2017). Animal-cell culture media: History, characteristics, and current issues. Reprod. Med. Biol., 16(2): 99-117. PMC5661806.
  • Schwerdt, C.E. & Fogh, J. (1957). The ratio of physical particles per infectious unit observed for poliomyelitis viruses. Virology, 4: 41-52.
FluxMPS™ Platform

FluxMPS™ — Precision Cell Culture Media for Microphysiological Systems

Built for the architecture of the future. Not the flask of the past.

Traditional cell culture media were formulated for static well plates and flasks — environments that tolerate impurities, precipitates, and particle loads that would immediately compromise a microfluidic system. FluxMPS™ was designed from the ground up for Organ-on-Chip (OoC), Tissue-on-Chip (ToC), and Lab-on-Chip (LoC) platforms, where the medium itself is part of the instrument.

Purity That Protects Your Platform

FluxMPS™ is purified to 0.04 microns — finer than any ready-to-use cell culture media currently available. At this level, the microscopic particulates and protein aggregates that silently block micro-channels, disrupt laminar flow, and generate false biological signals are eliminated before the media ever reaches your chip.

The result: your platform stays operational, your data stays clean, and your biology drives the result — not your media.

Engineered for Flow, Not Just Growth

The name FluxMPS™ reflects its core design principle. Every component is optimized for consistent, laminar flow performance across:

  • Complex micro-channel geometries
  • Capillary-bed and vascular simulations
  • Long-term automated perfusion studies running continuously for weeks

Zero-clogging performance is not a feature — it is the baseline specification.

Applications & Performance

Application What FluxMPS™ Delivers
Microfluidics Stable shear stress; no channel blockage
Metabolic Tracing Ultra-pure matrix with no contaminant interference
Long-term Perfusion Consistent formulation stability over weeks of continuous flow
Organ-on-Chip Optical clarity for real-time imaging and integrated biosensing

Regulatory Foundation

FluxMPS™ is formulated to support FDA-recognized physiological modeling standards, providing a validated, reproducible media foundation for drug discovery, toxicology screening, and translational research. When your downstream data needs to stand up to regulatory scrutiny, your upstream media cannot be an afterthought.

The Bottom Line

Microfluidic platforms are precision instruments. They require precision inputs.

FluxMPS™ is the only ready-to-use cell culture medium engineered specifically to meet that standard — protecting your chip, your cells, and your science.

Satisfaction
Quality Rating
Value Rating
Style Rating
X